E2F1 induced neuroblastoma cell migration and invasion via activation of CENPE/FOXM1 signaling pathway

References

• Friedman GK, Castleberry RP. Changing trends of research and treatment in infant neuroblastoma. Pediatr Blood Cancer. 2007;49(7 Suppl):1060–1065.
   PubMed Web of Science ®Google Scholar
• Kushner BH, Cheung NK. Neuroblastoma–from genetic profiles to clinical challenge. N Engl J Med. 2005;353(21):2215–2217.
   PubMed Web of Science ®Google Scholar
• Balamuth NJ, Wood A, Wang Q, et al. Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Research. 2010;70(7):2749–2758.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang Q, Jiang X, et al. Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN. Theranostics. 2019;9(4):986–1000.
   PubMed Web of Science ®Google Scholar
• Rader J, Russell MR, Hart LS, et al. Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clin Cancer Res. 2013;19(22):6173–6182
   PubMed Web of Science ®Google Scholar
• Cole KA, Maris JM. New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcome. Clin Cancer Res. 2012;18(9):2423–2428.
   PubMed Web of Science ®Google Scholar
• Carpenter EL, Mossé YP. Targeting ALK in neuroblastoma–preclinical and clinical advancements. Nat Rev Clin Oncol. 2012;9(7):391–399.
   PubMed Web of Science ®Google Scholar
• Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–1582.
   PubMed Web of Science ®Google Scholar
• Hobbie WL, Moshang T, Carlson CA, et al. Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma. Pediatr Blood Cancer. 2008;51(5):679–683.
   PubMed Web of Science ®Google Scholar
• Huang Y, Lin L, Liu X, et al. BubR1 phosphorylates CENP-E as a switch enabling the transition from lateral association to end-on capture of spindle microtubules. Cell Res. 2019;29(7):562–578.
   PubMed Web of Science ®Google Scholar
• Wu M, Chang Y, Hu H, et al. LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores. Nat Commun. 2019;10(1):273.
   PubMed Web of Science ®Google Scholar
• Testa JR, Zhou JY, Bell DW, et al. Chromosomal localization of the genes encoding the kinetochore proteins CENPE and CENPF to human chromosomes 4q24–>q25 and 1q32–>q41, respectively, by fluorescence in situ hybridization. Genomics. 1994;23(3):691–693.
   PubMed Web of Science ®Google Scholar
• Hitti E, Bakheet T, Al-Souhibani N, et al. Systematic analysis of AU-Rich element expression in cancer reveals common functional clusters regulated by key RNA-Binding proteins. Cancer Res. 2016;76(14):4068–4080.
   PubMed Web of Science ®Google Scholar
• Shan L, Zhao M, Lu Y, et al. CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1. Int J Oncol. 2019;55(1):257–266. Jul PubMed PMID: 31115500; eng.
   PubMed Web of Science ®Google Scholar
• Rajasekaran S, Nagarajha Selvan LD, Dotts K, et al. Non-coding and coding transcriptional profiles are significantly altered in pediatric retinoblastoma tumors. Front Oncol. 2019;9:221.
   PubMed Web of Science ®Google Scholar
• Choi EH, Kim KP. E2F1 facilitates DNA break repair by localizing to break sites and enhancing the expression of homologous recombination factors. Exp Mol Med. 2019;51(9):1–12.
   Web of Science ®Google Scholar
• DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med. 2006;6(7):739–748.
   PubMed Web of Science ®Google Scholar
• Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002;3(1):11–20.
   PubMed Web of Science ®Google Scholar
• Tsantoulis PK, Gorgoulis VG. Involvement of E2F transcription factor family in cancer. Eur J Cancer. 2005;41(16):2403–2414.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Liang ML, Hsieh TH, Ng KH, et al. Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas. Oncotarget 2016;7(15):19723–19737.
   PubMedGoogle Scholar
• Liang Y, Ahmed M, Guo H, et al. LSD1-Mediated epigenetic reprogramming drives CENPE expression and prostate cancer progression. Cancer Res. 2017;77(20):5479–5490.
   PubMed Web of Science ®Google Scholar
• Elie-Caille C, Lascombe I, Péchery A, et al. Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure. Mol Cell Biochem. 2020;471(1-2):113–127.
   PubMed Web of Science ®Google Scholar
• Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68(18):3033–3046.
   PubMed Web of Science ®Google Scholar
• Luo Y, Zhu YT, Ma LL, et al. Characteristics of bladder transitional cell carcinoma with E-cadherin and N-cadherin double-negative expression. Oncol Lett. 2016;12(1):530–536.
   PubMed Web of Science ®Google Scholar
• Zheng X, Lin J, Wu H, et al. Forkhead box (FOX) G1 promotes hepatocellular carcinoma epithelial-Mesenchymal transition by activating wnt signal through forming T-cell factor-4/beta-catenin/FOXG1 complex. J Exp Clin Cancer Res. 2019;38(1):475.
   PubMed Web of Science ®Google Scholar
• Choe KN, Nicolae CM, Constantin D, et al. HUWE1 interacts with PCNA to alleviate replication stress. EMBO Rep. 2016;17(6):874–886.
   PubMed Web of Science ®Google Scholar
• Tan Z, Wortman M, Dillehay KL, et al. Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth. Mol Pharmacol. 2012;81(6):811–819.
   PubMed Web of Science ®Google Scholar
• Engelmann D, Pützer BM. The dark side of E2F1: in transit beyond apoptosis. Cancer Res. 2012;72(3):571–575.
   PubMed Web of Science ®Google Scholar
• Lin M, Liu Y, Ding X, et al. E2F1 transactivates IQGAP3 and promotes proliferation of hepatocellular carcinoma cells through IQGAP3-mediated PKC-alpha activation. Am J Cancer Res. 2019;9(2):285–299.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang Q, Liang Y. MicroRNA-598 acts as an inhibitor in retinoblastoma through targeting E2F1 and regulating AKT pathway. J Cell Biochem. 2020;121(3):2294–2302.
   PubMed Web of Science ®Google Scholar
• Molina-Privado I, Rodríguez-Martínez M, Rebollo P, et al. E2F1 expression is deregulated and plays an oncogenic role in sporadic burkitt’s lymphoma. Cancer Res. 2009;69(9):4052–4058.
   PubMed Web of Science ®Google Scholar
• Xu J, Chen G, Zhang Y, et al. LINC00511 promotes osteosarcoma tumorigenesis and invasiveness through the miR-185-3p/E2F1 axis. Biomed Res Int. 2020;2020:1974506.
   PubMed Web of Science ®Google Scholar
• Yin J, Fu W, Dai L, et al. ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1. Sci Rep. 2017;7(1):4430.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang J, He Y, et al. hsa_circ_0061140 knockdown reverses FOXM1-Mediated cell growth and metastasis in ovarian cancer through miR-370 sponge activity. Mol Ther Nucleic Acids. 2018;13:55–63.
   PubMedGoogle Scholar
• Xiao Z, Jia Y, Jiang W, et al. FOXM1: a potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma. Thorac Cancer. 2018;9(8):997–1004.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qiao WB, Shan L. Expression and functional characterization of FOXM1 in non-small cell lung cancer. Onco Targets Ther. 2018;11:3385–3393.
   PubMed Web of Science ®Google Scholar
• Jin H, Li XJ, Park MH, et al. FOXM1-mediated downregulation of uPA and MMP9 by 3,3'-diindolylmethane inhibits migration and invasion of human colorectal cancer cells. Oncol Rep. 2015;33(6):3171–3177.
   PubMed Web of Science ®Google Scholar
• Wang Z, Park HJ, Carr JR, et al. FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors. Cancer Res. 2011;71(12):4292–4302.
   PubMed Web of Science ®Google Scholar
• Decaesteker B, Denecker G, Van Neste C, et al. TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets. Nat Commun. 2018;9(1):4866.
   PubMed Web of Science ®Google Scholar